The ATXN2 gene helps nerve cells manage RNA, a molecule they use to make proteins, and supports normal signaling in the brain and spinal cord. This gene plays an important role in keeping movement, speech, and coordination steady from day to day. Certain repeat expansions in the ATXN2 gene can cause spinocerebellar ataxia type 2, which often leads to worsening balance problems, shaky movements, and slurred speech. Some shorter expansions are also linked to a higher chance of amyotrophic lateral sclerosis, also called ALS.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide activities in the body. Some genes contain the directions for building proteins, the parts of cells that do much of the work. Other genes mainly help regulate when certain activities happen, where they occur, and how strongly they take place. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. If you want to look into this topic in more detail, you can learn more in LearnHub.
Overview
ATXN2Gene function
What if the gene works
The ATXN2 gene helps cells manage RNA, a working copy of genetic instructions. It supports protein production and stress responses, especially in nerve cells.
Risk
What if the gene does not work
Variants in the ATXN2 gene most often cause spinocerebellar ataxia type 2, with balance, coordination, speech, and eye movement problems. Milder or more severe changes can affect onset and severity, and some expansions also raise ALS risk.
Treatment
What does that mean for your treatment
No ATXN2-specific treatment or drug choice is currently established in clinical guidelines for people with a pathogenic variant in the ATXN2 gene. The ATXN2 gene is being studied as a treatment target, including antisense medicines (drugs designed to lower the gene's message) for spinocerebellar ataxia type 2 and some forms of ALS.
Conditions associated with ATXN2
Gene function
What if the gene works
Inside your cells, the ATXN2 gene helps manage RNA messages, the working copies of genetic instructions. It supports when proteins are made and how cells adjust during everyday stress. This background helps explain what the ATXN2 gene does in normal cell activity.
The ATXN2 gene helps cells organize RNA messages after they are copied from DNA. This helps the right messages stay available at the right time for normal cell work.
Its protein works near the machinery that makes proteins to fine tune when some proteins are produced. This supports smooth, controlled protein production, especially in active cells such as nerve cells.
During short periods of cell stress, ATXN2 helps gather RNA messages into stress granules (temporary storage spots). This lets cells pause some protein production and restart it in a more organized way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most clinically important variants in the ATXN2 gene are CAG repeat expansions, which make the ataxin-2 protein unusually long and more likely to misfold, clump, and disrupt how cells handle RNA. In practice, how ATXN2 gene variants affect protein function depends on size: intermediate expansions usually change cell behavior more mildly, while larger expansions often cause greater toxicity. This ATXN2 gene variant effect is linked to earlier and more pronounced features in spinocerebellar ataxia type 2.
How variants are linked to conditions
Pathogenic repeat expansions in the ATXN2 gene cause spinocerebellar ataxia type 2, an inherited condition linked to balance problems, poor coordination, and slow eye movements. Some people with spinocerebellar ataxia type 2 caused by the ATXN2 gene also develop tremor or parkinsonism features. Shorter, intermediate repeat expansions in the ATXN2 gene are also associated with a higher risk of amyotrophic lateral sclerosis, but they do not mean a person will definitely develop ALS.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATXN2, risk is shaped mostly by the specific gene change and family history. Longer repeat expansions are more strongly linked to developing an ATXN2-related condition and often to symptoms starting earlier. There is not enough evidence to say that lifestyle changes lower this genetic risk.
Inheritance of ATXN2 variants
Most disease-causing changes in the ATXN2 gene are inherited in an autosomal dominant pattern. In practical terms, this ATXN2 inheritance pattern means a parent carrying the variant can pass it to a son or daughter, and each child has a 1 in 2, or 50%, chance of inheriting it. Men and women are affected and can pass the variant on equally because the ATXN2 gene is on chromosome 12, not on a sex chromosome.
What does my ATXN2 result mean for my family?
A disease-causing change in the ATXN2 gene usually means the condition can run in families in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same change. In many families, each child of someone with this result has a 1 in 2, or 50%, chance of inheriting it. Family impact can differ for ATXN2 results linked to increased risk rather than a confirmed inherited condition.
Genetic information
Genetic testing
How you find out about variants
ATXN2 genetic testing usually uses a blood or saliva sample to read the DNA in the ATXN2 gene and measure the length of its CAG repeat. Results can show whether you carry a variant or repeat expansion linked to spinocerebellar ataxia type 2, and they may also help clarify what is happening in a family.
When should I consider getting a genetic test?
Consider testing for changes in the ATXN2 gene if you or close relatives have an inherited pattern of balance problems, poor coordination, slurred speech, or slow eye movements, especially if spinocerebellar ataxia type 2 has been diagnosed in the family. Testing can help confirm the cause and clarify who else in the family may also be at risk.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but what it can tell you depends on the condition and the type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how strongly it acts, or how sensitive someone is to side effects. This helps explain why the same treatment works well for one person, has little effect in another, or feels harder to tolerate, and these differences are a normal part of human biology.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medications. It looks at gene drug patterns to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the ATXN2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general questions about symptoms, side effects, or treatment choices are best discussed with your doctor.
History
Throughout history, people have described families in which several relatives developed worsening balance, speech, and eye movement problems over time. In the 1990s, researchers traced one important cause of this inherited pattern, spinocerebellar ataxia type 2, to the ATXN2 gene. This was part of a broader period in genetics when scientists linked several neurologic conditions to repeated stretches in DNA. From these first observations, research expanded steadily. Later studies showed that certain longer repeats in the ATXN2 gene could also raise the chance of amyotrophic lateral sclerosis, often called ALS, in some people. These discoveries made the ATXN2 gene an important part of the history of inherited neurologic disease research.